CRISPR-CAS9: Programming Your HealthGenetic engineering & the future of healthcare

June 30, 2019

Genetic engineering is the deliberate modification, artificial manipulation, and recombination of the genetic material of an organism to change its characteristics. These techniques can be used as a therapy for certain diseases. This whitepaper will dive into the world of genetic engineering and its future applications and possibilities.

Spotlight

RetroVirox Inc.

RetroVirox is a privately-held biotechnology company founded in 2008 and dedicated to discovering new treatments for patients with infectious diseases. RetroVirox is developing novel drugs to eradicate HIV infection and also to treat infections with highly pathogenic viruses (arenavirus) utilizing company's proprietary technologies.

OTHER WHITEPAPERS
news image

Connecting materials sciences with fungal biology: a sea of possibilities

whitePaper | March 1, 2022

The Special Issue “Connecting materials science with fungal biology” celebrates recent breakthroughs in the fabrication of fungal-based materials, all of which have been made possible by the interdisciplinary and transdisciplinary collaboration of fungal biologists and biotechnologists with artists, designers, materials scientists, and architects

Read More
news image

Multi-Attribute Methods for Biopharmaceutical Analysis

whitePaper | December 5, 2022

The adoption of LC-MS-based multi-attribute method (MAM) analysis for routine monitoring of biotherapeutic variation has progressed greatly over the last five years.

Read More
news image

Long-term follow-up studies of cell and gene therapies

whitePaper | September 29, 2022

The market is experiencing a surge in the availability of cell and gene therapies (CGTs); it’s estimated that by 2025 as many as 20 will be introduced into the US each year.1,2

Read More
news image

Pioneering Cell and Gene Therapy Solutions From Discovery to the Clinic

whitePaper | April 14, 2020

Your vision is to create revolutionary cell and gene therapies to treat life threatening diseases. Bio-Techne and its family of brands is on this journey with you. As a full-solution ancillary reagent and services provider, we will stand by you, providing flexible and pioneering tools to simplify your workflow. From CAR T cells to pluripotent stem cells, let us help you get your therapy to the patients that need it

Read More
news image

Automated Extraction of High Molecular Weight DNA

whitePaper | November 14, 2019

SmartExtraction significantly simplifies the entire automated workflow of DNA extraction, setting new standards with regard to efficiency, yield and quality of the DNA.

Read More
news image

Imaweld® heat sealable & weldable tube bioprocess media

whitePaper | February 3, 2023

Imaweld® is thermoplastic elastomer tubing particularly designed to transfer critical fluid in pharmaceutical and biopharmaceutical applications.

Read More

Spotlight

RetroVirox Inc.

RetroVirox is a privately-held biotechnology company founded in 2008 and dedicated to discovering new treatments for patients with infectious diseases. RetroVirox is developing novel drugs to eradicate HIV infection and also to treat infections with highly pathogenic viruses (arenavirus) utilizing company's proprietary technologies.

Events